Acta Oncol

ISSN	1651-226X
ISSN-L	0284-186X
IUID	1b8e068afff74baa839bbeac79224add
Modified	2020-11-27T13:12:56.352Z
Created	2018-12-05T11:20:38.094Z

Year 2025

PubMed DOI Crossref

Baseline laboratory values and metastatic burden predict survival in addition to IMDC risk in real-world renal cell carcinoma patients treated with ipilimumab-nivolumab.

Kheir A, Johannsdottir B, Grönn-Weiss A, ..., Lindskog M, Harmenberg U

Acta Oncol 64 (-) 1355-1364 [2025-10-03; online 2025-10-03]

Year 2023

PubMed DOI Crossref

Strict self-isolation did not protect Swedish cancer patients on active treatment from the risk of becoming seropositive for SARS-CoV-2.

Ginman B, Pahnke S, Freyhult E, ..., Enblad G, Glimelius I

Acta Oncol 62 (12) 1707-1715 [2023-12-00; online 2023-11-25]

PubMed DOI Crossref

Ki67 and prostate specific antigen are prognostic in metastatic hormone naïve prostate cancer.

Spyratou V, Freyhult E, Bergh A, ..., Welén K, Josefsson A

Acta Oncol 62 (12) 1698-1706 [2023-12-00; online 2023-09-15]

PubMed DOI Crossref

The BioLymph study - implementing precision medicine approaches in lymphoma diagnostics, treatment and follow-up: feasibility and first results.

Smedby KE, Wästerlid T, Tham E, ..., Sonnevi K, Rosenquist R

Acta Oncol 62 (6) 560-564 [2023-06-00; online 2023-07-06]

Year 2022

PubMed DOI Crossref

Association between menopausal hormone therapy use and mortality risk: a Swedish population-based matched cohort study.

Simin J, Khodir H, Fornes R, Tamimi RM, Brusselaers N

Acta Oncol 61 (5) 632-640 [2022-05-00; online 2022-02-07]

PubMed DOI Crossref

Circulating tumor DNA (ctDNA) in adjuvant therapy of early stage colon cancer: current status and future perspectives.

Merk C, Martling A, Lindberg J, ..., Taieb J, Lind P

Acta Oncol 61 (4) 523-530 [2022-04-00; online 2022-02-09]

Year 2021

PubMed DOI Crossref

Prediagnostic use of estrogen-only therapy is associated with improved colorectal cancer survival in menopausal women: a Swedish population-based cohort study.

Simin J, Liu Q, Wang X, ..., Engstrand L, Brusselaers N

Acta Oncol 60 (7) 881-887 [2021-07-00; online 2021-04-16]

PubMed DOI Crossref

PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS.

Abdulla M, Alexsson A, Sundström C, ..., Hollander P, Amini RM

Acta Oncol 60 (4) 531-538 [2021-04-00; online 2021-02-12]

PubMed DOI Crossref

Surgery of metastatic melanoma after systemic therapy - the SUMMIST trial: study protocol for a randomized controlled trial.

Holmberg CJ, Katsarelias D, Jespersen H, ..., Ny L, Olofsson Bagge R

Acta Oncol 60 (1) 52-55 [2021-01-00; online 2020-11-30]

Year 2020

PubMed DOI Crossref

Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis.

Nunes L, Aasebø K, Mathot L, ..., Sjöblom T, Glimelius B

Acta Oncol 59 (4) 417-426 [2020-04-00; online 2020-01-10]

Year 2019

PubMed DOI Crossref

Menopausal hormone therapy and biliary tract cancer: a population-based matched cohort study in Sweden.

Kilander C, Lagergren J, Konings P, Sadr-Azodi O, Brusselaers N

Acta Oncol 58 (3) 290-295 [2019-03-00; online 2019-01-18]

Year 2018

PubMed DOI Crossref

U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.

Glimelius B, Melin B, Enblad G, ..., Palmqvist R, Sjöblom T

Acta Oncol 57 (2) 187-194 [2018-02-00; online 2017-06-20]

Year 2016

PubMed DOI Crossref

Sporadic occurrence of non-diagnosed IgG4-related disease in lymphoma patients with a previous Sjögren's syndrome diagnosis.

Vasaitis L, Sundström C, Backlin C, Nordmark G, Baecklund E

Acta Oncol 55 (9-10) 1139-1144 [2016-05-19; online 2016-05-19]

Year 2015

PubMed DOI Crossref

FGF2 as a potential prognostic biomarker for proneural glioma patients.

Sooman L, Freyhult E, Jaiswal A, ..., Bergqvist M, Ekman S

Acta Oncol 54 (3) 385-394 [2015-03-00; online 2014-09-29]

Year 2013

PubMed DOI Crossref

GWAS-based association between RWDD3 and TECTA variants and paclitaxel induced neuropathy could not be confirmed in Scandinavian ovarian cancer patients.

Bergmann TK, Vach W, Feddersen S, ..., Herrstedt J, Brosen K

Acta Oncol 52 (4) 871-874 [2013-05-00; online 2012-08-09]